University of Dhaka Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT01589445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

University of Dhaka | University of Dhaka, Bangladesh

Active Ingredients

Drugs in Phase 4 Trials (2)

pioglitazone (actos) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2